Zusammenfassung
Nach kurzen Darstellungen der für die Leitlinie relevanten diagnostischen Begriffe folgen die Empfehlungen der Leitlinie zu den Bereichen Diagnostik und Dokumentation.
(Autoren vorige Leitlinienversion: Anil Batra, Christoph Kröger, Peter Lindinger, Ulf Ratje, Kay Uwe Petersen)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
Das nachfolgende Glossar wurde vom Erstautor auch für die Leitlinie „Medikamentenbezogene Störungen“, AWMF – Registernummer 038–025, S. 24 ff verfasst und in Auszügen verwendet.
- 2.
Zum Teilaspekt „E-Zigaretten oder verwandte Produkte“ ergab die systematische Recherche keine Studien. Dennoch sollen sie analog zu Tabak behandelt werden. Dieser Aspekt der Empfehlung ist nur ein Klinischer Konsenspunkt.
- 3.
Zum Teilaspekt „verwandte Produkte“ ergab die systematische Recherche keine Studien. Dennoch sollen sie analog zu Tabak behandelt werden. Dieser Aspekt der Empfehlung ist nur ein Klinischer Konsenspunkt.
Literatur
Batra A. Tabakabhängigkeit: Biologische und psychosoziale Entstehungsbedingungen und Therapiemöglichkeiten. Darmstadt: Steinkopf;2000.
Batra A, Kröger C, Lindinger P, Pötschke-Langer M. Qualitätsmerkmale von Raucherbehandlungen–die Notwendigkeit für definierte Standards. Sucht. 2008;54(2):95–100.
Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P III, Jarvis MJ, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res. 2020;22(7):1086–97.
Bolt DM, Piper ME, McCarthy DE, Japuntich SJ, Fiore MC, Smith SS, et al. The Wisconsin Predicting Patients’ Relapse questionnaire. Nicotine Tob Res. 2009;11(5):481–92.
Borland R, Partos TR, Cummings KM. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res. 2012;14(12):1483–7.
Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Multivariate framework of the brief questionnaire of smoking urges. Drug Alcohol Depend. 2007;90(2-3):234–42.
Clemente Jiménez ML, Pérez Trullén A, Rubio Aranda E, Marrón Tundidor R, Rodríguez Ibáñez ML, Herrero LI. A version of DSM-IV criteria adapted for adolescents and applied to young smokers. Arch Bronconeumol. 2003;39(7):303–9.
Courvoisier D, Etter J-F. Using item response theory to study the convergent and discriminant validity of three questionnaires measuring cigarette dependence. Psychol Addict Behav. 2008;22(3):391.
Courvoisier DS, Etter J-F. Comparing the predictive validity of five cigarette dependence questionnaires. Drug Alcohol Depend. 2010;107(2-3):128–33.
Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7–16.
DiFranza JR, Savageau JA, Fletcher K, Ockene JK, Rigotti NA, McNeill AD, et al. Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (Development and Assessment of Nicotine Dependence in Youths) study. Arch Pediatr Adolesc Med. 2002;156(4):397–403.
Dilling H, Mombour W, Schmidt M. Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F): Klinisch-diagnostische Leitlinien. 9. Aufl. Bern: Huber;2014.
Donny EC, Dierker LC. The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend. 2007;89(1):93–6.
van Eerd EA, van der Meer RM, van Schayck OC, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;(8):Art. No.: CD010744. https://doi.org/10.1002/14651858.CD010744.pub2.
Etter J-F. A comparison of the content-, construct-and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend. 2005;77(3):259–68.
Etter J-F. Comparing the validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend. 2008;95(1-2):152–9.
Etter JF, Ussher M, Hughes JR. A test of proposed new tobacco withdrawal symptoms. Addiction. 2013;108(1):50–9.
Etter J-F, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: the cigarette dependence scale. Neuropsychopharmacology. 2003;28(2):359–70.
Etter J-F, Le Houezec J, Huguelet P, Etter M. Testing the cigarette dependence scale in 4 samples of daily smokers: psychiatric clinics, smoking cessation clinics, a smoking cessation website and in the general population. Addict Behav. 2009;34(5):446–50.
European Network for Smoking and Tobacco Prevention (ENSP). Guidelines for treating tobacco dependence. Brüssel: European Network for Smoking and Tobacco Prevention;2018.
Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res. 2012;14(1):75–8.
Fagerström K, Furberg H. A comparison of the Fagerström Test for Nicotine Dependence and smoking prevalence across countries. Addiction. 2008;103(5):841–5.
Fagerström K, Rutqvist LE, Hughes JR. Snus as a smoking cessation aid: a randomized placebo-controlled trial. Nicotine Tob Res. 2012;14(3):306–12.
Fagerström K-O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav. 1978;3(3-4):235–41.
Fagerström K-O, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12(2):159–82.
Fernández E, Lugo A, Clancy L, Matsuo K, La Vecchia C, Gallus S. Smoking dependence in 18 European countries: hard to maintain the hardening hypothesis. Prev Med. 2015;81:314–9.
Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction. 2011;106(3):631–8.
Fiore M, Bailey W, Cohen S, Dorfman S, Goldstein M, Gritz E, et al. Smoking cessation. Clinical practice guideline No 18; 1996.
Fiore MC, Jaén C, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Departement of Health and Human Services Public Health Service; 2008.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–800.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstöm KO. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.
Hendricks PS, Prochaska JJ, Humfleet GL, Hall SM. Evaluating the validities of different DSM-IV-based conceptual constructs of tobacco dependence. Addiction. 2008;103(7):1215–23.
Hoch E, Muehlig S, Höfler M, Lieb R, Wittchen HU. How prevalent is smoking and nicotine dependence in primary care in Germany? Addiction. 2004;99(12):1586–98.
Hughes JR, Oliveto AH, Riggs R, Kenny M, Liguori A, Pillitteri JL, et al. Concordance of different measures of nicotine dependence: two pilot studies. Addict Behav. 2004b;29(8):1527–39.
Hughes JR, Helzer JE, Lindberg SA. Prevalence of DSM/ICD-defined nicotine dependence. Drug Alcohol Depend. 2006;85(2):91–102.
Huh J, Timberlake DS. Do smokers of specialty and conventional cigarettes differ in their dependence on nicotine? Addict Behav. 2009;34(2):204–11.
Kandel D, Schaffran C, Griesler P, Samuolis J, Davies M, Galanti R. On the measurement of nicotine dependence in adolescence: Comparisons of the mFTQ and a DSM-IV–based scale. J Pediatr Psychol. 2005;30(4):319–32.
Kastaun S, Scholz E, Kotz D. Hängt Tabakrauchen mit ängstlich-depressiver Symptomatik zusammen? Ergebnisse einer repräsentativen Befragung der Bevölkerung Deutschlands (DEBRA Studie). Das Gesundheitswesen. 2019;81(08/09):7D–5.
Kotz D, Böckmann M, Kastaun S. Nutzung von Tabak und E-Zigaretten sowie Methoden zur Tabakentwöhnung in Deutschland. Eine repräsentative Befragung in 6 Wellen über 12 Monate (die DEBRA-Studie). Dtsch Arztebl Int. 2018;115:235–42.
Kotz D, Batra A, Kastaun S. Rauchstoppversuche und genutzte Entwöhnungsmethoden. Dtsch Arztebl Int. 2020;117(1-2):7–13.
McCullough A, Fisher M, Goldstein AO, Kramer KD, Ripley-Moffitt C. Smoking as a vital sign: prompts to ask and assess increase cessation counseling. J Am Board Fam Med. 2009;22(6):625–32.
Meneses-Gaya ICD, Zuardi AW, Loureiro SR, Crippa JADS. Psychometric properties of the Fagerström test for nicotine dependence. J Bras Pneumol. 2009;35(1):73–82.
Müller V, Mucha RF, Ackermann K, Pauli P. Die Erfassung des Cravings bei Rauchern mit einer deutschen Version des „Questionnaire on Smoking Urges“ (QSU-G). Z Klin Psychol Psychother. 2001;30(3):164–71.
National Institute for Health and Care Excellence (NICE). Stop Smoking Interventions and Services. London: NICE;2018.
Panday S, Reddy SP, Ruiter RA, Bergström E, de Vries H. Nicotine dependence and withdrawal symptoms among occasional smokers. J Adolesc Health. 2007;40(2):144–50.
Pedersen W, Von Soest T. Smoking, nicotine dependence and mental health among young adults: a 13-year population-based longitudinal study. Addiction. 2009;104(1):129–37.
Pérez-Ríos M, Santiago-Pérez MI, Alonso B, Malvar A, Hervada X, de Leon J. Fagerstrom test for nicotine dependence vs heavy smoking index in a general population survey. BMC Public Health. 2009;9(1):493.
Perkins KA, Gerlach D, Broge M, Grobe JE, Sanders M, Fonte C, et al. Dissociation of nicotine tolerance from tobacco dependence in humans. J Pharmacol Exp Ther. 2001;296(3):849–56.
Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, et al. Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine Tob Res. 2008;10(6):1009–20.
Prokhorov AV, Koehly LM, Pallonen UE, Hudmon KS. Adolescent nicotine dependence measured by the modified Fagerström Tolerance Questionnaire at two time points. J Child Adolesc Subst Abuse. 1998;7(4):35–47.
Prokhorov AV, Warneke C, de Moor C, Emmons KM, Jones MM, Rosenblum C, et al. Self-reported health status, health vulnerability, and smoking behavior in college students: implications for intervention. Nicotine Tob Res. 2003;5(4):545–52.
Rojas NL, Killen JD, Haydel KF, Robinson TN. Nicotine dependence among adolescent smokers. Arch Pediatr Adolesc Med. 1998;152(2):151–6.
Santos JDPD, Silveira DV, Oliveira DFD, Caiaffa WT. Instrumentos para avaliação do tabagismo: uma revisão sistemática. Ciência Saúde Coletiva. 2011;16(12):4707–20.
Schumann A, Rumpf HJ, Hapke U, John U. Deutsche Version des Fagerström-Test for Nicotine Dependence (FTND)(FTND-d) und des Heaviness of Smoking Index (HIS) (HIS-d). In: Glöckner-Rist A, Rist F, Küfner H, editors. Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). 3. Aufl. Mannheim: Institut für Umfragen, Methoden und Analysen (ZUMA) e. V;2002.
Shiffman S, Waters AJ, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004;6(2):327–48.
Spek V, Lemmens F, Chatrou M, van Kempen S, Pouwer F, Pop V. Development of a smoking abstinence self-efficacy questionnaire. Int J Behav Med. 2013;20(3):444–9.
Tiffany ST, Drobes DJ. The development and initial validation of a questionnaire on smoking urges. Br J Addict. 1991;86(11):1467–76.
Uysal MA, Kadakal F, Karşidağ C, Bayram NG, Uysal O, Yilmaz V. Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis. Tuberk Toraks. 2004;52(2):115–21.
West R, Brown J. Theory of addiction. Chichester: Wiley;2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
3.1 Elektronisches Zusatzmaterial
Rights and permissions
Copyright information
© 2022 DGPPN; DG-Sucht
About this chapter
Cite this chapter
Batra, A., Petersen, K.U., Hering, T., Kröger, C., Lindinger, P., Kotz, D. (2022). Diagnostik und Dokumentation. In: Batra, A., Petersen, K.U., Kiefer, F., Hoffmann, S. (eds) S3-Leitlinie Rauchen und Tabakabhängigkeit: Screening, Diagnostik und Behandlung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63679-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-63679-4_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-63678-7
Online ISBN: 978-3-662-63679-4
eBook Packages: Medicine (German Language)